Absci to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
VANCOUVER, Wash. and NEW YORK, Dec. 28, 2023 (GLOBE NEWSWIRE) — Absci Corporation (Nasdaq:ABSI), a generative AI drug creation company, today announced the company will be participating in the upcoming 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
Related news for (ABSI)
- MoBot’s Stock Market Highlights – 05/14/25 09:00 AM
- Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease
- 24/7 Market News Snapshot 13 May, 2025 – Absci Corporation Common Stock (NASDAQ:ABSI)
- Don’t Miss Out: MoBot’s Latest Stock Updates 04/11/25 03:00 PM
- MoBot alert highlights: NASDAQ: SHPH, NASDAQ: ONVO, NASDAQ: ABSI, NASDAQ: RXRX, NASDAQ: CERT (04/10/25 07:00 PM)